Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma, Head And Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03624231
What this trial is testing

Feasibility & Efficacy of Durvalumab+Tremelimumab+RT and Durvalumab+RT in Non-resect. Locally Advanced HPVnegativ HNSCC

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Ulrich Keilholz 18
Large-scale testing (Phase 3)UnknownNCT03815903
What this trial is testing

Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Malignant Neoplasm
Barretos Cancer Hospital 434
Testing effectiveness (Phase 2)Study completedNCT01084083
What this trial is testing

Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

Who this might be right for
Head and Neck CancerPrecancerous Condition
Eastern Cooperative Oncology Group 90
Not applicableUnknownNCT05900583
What this trial is testing

Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.

Who this might be right for
Minimal Residual DiseaseEsophageal Squamous Cell Carcinoma
Guangdong Provincial People's Hospital 50
Testing effectiveness (Phase 2)WithdrawnNCT04987996
What this trial is testing

GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients

Who this might be right for
Metastatic MelanomaHead and Neck Squamous Cell Carcinoma
Providence Health & Services
Testing effectiveness (Phase 2)Looking for participantsNCT07086469
What this trial is testing

Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
ToripalimabSurufatinibNeoadjuvant Immunochemotherapy+2 more
Sun Yat-sen University 69
Testing effectiveness (Phase 2)Study completedNCT04005170
What this trial is testing

Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Unresectable Esophageal Cancer
Mian XI 42
Not applicableUnknownNCT03202173
What this trial is testing

The Diagnosis of NPC Using the Probe-based Confocal Laser Endomicroscopy

Who this might be right for
Nasopharyngeal CarcinomaSquamous Cell Carcinoma of the Head and Neck
Eye & ENT Hospital of Fudan University 31
Early research (Phase 1)Study completedNCT00935961
What this trial is testing

RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer

Who this might be right for
HEAD & NECK Cancer
Memorial Sloan Kettering Cancer Center 18
Not applicableActive Not RecruitingNCT02984410
What this trial is testing

Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma

Who this might be right for
Oropharyngeal CancerSupraglottic Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC 112
Testing effectiveness (Phase 2)Ended earlyNCT03020823
What this trial is testing

To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
SynCore Biotechnology Co., Ltd. 10
Not applicableEnded earlyNCT01632969
What this trial is testing

Improving End of Life Care in Head and Neck Cancer

Who this might be right for
The Families or Next of Kin of Patients Treated at MSKCC for Non-cutaneous Squamous Cell Carcinomas of theUpper Aerodigestive Tract
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)UnknownNCT05265962
What this trial is testing

Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 85
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Study completedNCT00006361
What this trial is testing

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

Who this might be right for
Carcinoma of Unknown PrimaryHead and Neck CancerNon-melanomatous Skin Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03789097
What this trial is testing

Vaccination With Flt3L, Radiation, and Poly-ICLC

Who this might be right for
Non-Hodgkin's LymphomaMetastatic Breast CancerHead and Neck Squamous Cell Carcinoma
Icahn School of Medicine at Mount Sinai 17
Not applicableStudy completedNCT02892786
What this trial is testing

Detection in Peripheral Blood of Circulating Tumor Cells in Patient With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Institut de Cancérologie de Lorraine 40
Large-scale testing (Phase 3)Looking for participantsNCT07333274
What this trial is testing

Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head & Neck Squamous Cell CarcinomaHead & Neck Cancer
Shandong Cancer Hospital and Institute 335
Early research (Phase 1)Study completedNCT01872923
What this trial is testing

Dose Escalating Study for Amphinex-based PCI of Bleomycin.

Who this might be right for
Cutaneous or Sub-cutaneous Malignancies
PCI Biotech AS 3
Early research (Phase 1)Study completedNCT01351103
What this trial is testing

LGK974 in Patients With Malignancies Dependent on Wnt Ligands

Who this might be right for
Pancreatic CancerBRAF Mutant Colorectal CancerMelanoma+5 more
Novartis Pharmaceuticals 185
Next Page